Suppr超能文献

相似文献

1
A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity.
J Chem Inf Model. 2015 Feb 23;55(2):308-16. doi: 10.1021/ci500405g. Epub 2015 Jan 29.
3
Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Antiviral Res. 2009 Apr;82(1):51-8. doi: 10.1016/j.antiviral.2009.01.008. Epub 2009 Feb 6.
5
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Antiviral Res. 2007 Mar;73(3):228-31. doi: 10.1016/j.antiviral.2006.10.004. Epub 2006 Nov 10.
6
Rational development of neuraminidase inhibitor as novel anti-flu drug.
Mini Rev Med Chem. 2012 Oct;12(12):1273-81. doi: 10.2174/138955712802761997.
7
Virtual screening pipeline and ligand modelling for H5N1 neuraminidase.
Biochem Biophys Res Commun. 2009 Jun 12;383(4):445-9. doi: 10.1016/j.bbrc.2009.04.030. Epub 2009 Apr 14.
8
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
ChemMedChem. 2012 Sep;7(9):1527-36. doi: 10.1002/cmdc.201200155. Epub 2012 Jul 16.
9
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.
Nature. 2008 Jun 26;453(7199):1258-61. doi: 10.1038/nature06956. Epub 2008 May 14.
10
Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
Eur J Med Chem. 2010 Feb;45(2):536-41. doi: 10.1016/j.ejmech.2009.10.040. Epub 2009 Oct 31.

引用本文的文献

2
Computational investigation of naturally occurring anticancer agents in regulating Hedgehog pathway proteins.
PLoS One. 2024 Dec 3;19(12):e0311307. doi: 10.1371/journal.pone.0311307. eCollection 2024.
4
A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors.
Appl Biol Chem. 2021;64(1):69. doi: 10.1186/s13765-021-00639-w. Epub 2021 Sep 17.
6
Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants.
J Pharm Bioallied Sci. 2020 Nov;12(Suppl 2):S763-S767. doi: 10.4103/jpbs.JPBS_261_19. Epub 2020 Nov 5.
7
Review on natural products databases: where to find data in 2020.
J Cheminform. 2020 Apr 3;12(1):20. doi: 10.1186/s13321-020-00424-9.
10
Cheminformatics in Natural Product-based Drug Discovery.
Mol Inform. 2020 Dec;39(12):e2000171. doi: 10.1002/minf.202000171. Epub 2020 Sep 6.

本文引用的文献

1
Free Energy Calculations Reveal the Origin of Binding Preference for Aminoadamantane Blockers of Influenza A/M2TM Pore.
J Chem Theory Comput. 2013 Feb 12;9(2):1272-81. doi: 10.1021/ct300899n. Epub 2013 Jan 3.
2
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4312-7. doi: 10.1016/j.bmcl.2014.07.010. Epub 2014 Jul 18.
3
Lead- and drug-like compounds: the rule-of-five revolution.
Drug Discov Today Technol. 2004 Dec;1(4):337-41. doi: 10.1016/j.ddtec.2004.11.007.
4
Drawing the PDB: Protein-Ligand Complexes in Two Dimensions.
ACS Med Chem Lett. 2010 Aug 31;1(9):540-5. doi: 10.1021/ml100164p. eCollection 2010 Dec 9.
5
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review.
Infect Drug Resist. 2013 Nov 19;6:187-98. doi: 10.2147/IDR.S36601. eCollection 2013.
8
Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.
Curr Med Chem. 2012;19(34):5885-94. doi: 10.2174/092986712804143358.
9
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
ChemMedChem. 2012 Sep;7(9):1527-36. doi: 10.1002/cmdc.201200155. Epub 2012 Jul 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验